Backgrounds and Trainings in Cannabis Therapeutics of Dispensary Personnel.

Purpose: A growing body of scientific research indicates that oncology teams tend to offer individuals with cancer little clinical advice regarding medicinal cannabis (MC) and that individuals with cancer instead turn to cannabis dispensaries for MC guidance. Our objective was to investigate dispensary personnel's backgrounds and trainings in MC advising.
Methods: The study design was semistructured interviews across 13 states with cannabis dispensary personnel in managerial or client-facing positions. Of 38 recruited, 26 (68%) completed interview. The primary outcome was training in MC advising. Researchers targeted thematic saturation and adhered to Consolidated Criteria for Reporting Qualitative Research.
Results: Of 26 participants, 54% were female, with an average age of 40 (range: 22-64) years. Half worked in client-facing roles; half worked in managerial ones. Study participants endorsed passionate commitment to their profession, often motivated by personal experience with MC therapeutics. Cannabis dispensaries often privileged sales skills over cannabis therapeutics knowledge when hiring, resulting in uneven baseline levels of cannabis therapeutics expertise among staff. Most participants reported workplace cannabis therapeutics training to be unstandardized and weak. They described dispensary personnel as resourceful in pursuing cannabis knowledge, self-financing learning in off-hours, sampling dispensary products, and exchanging knowledge. Nearly half the participants called for quality, standardized cannabis therapeutics training for dispensary personnel.
Conclusion: The many oncology teams who defer to dispensary personnel regarding MC advising rely on a workforce who views themselves as unevenly trained. Further research should include a national survey of cannabis dispensary personnel to learn whether these findings hold true in a larger sample. If so, the oncology community must determine the best approach to clinically advising individuals with cancer about MC.
Competing Interests: Ilana M. BraunResearch Funding: Cannex Scientific Peter R. ChaiStock and Other Ownership Interests: Biobot AnalyticsResearch Funding: E Ink Corporation Donald I. AbramsStock and Other Ownership Interests: Lumen, Cannformatics, WellkasaHonoraria: Metagenics Australia, L-Nutra, GW PharmaceuticalsConsulting or Advisory Role: Clever Leaves, Maui Grown Therapies, Wellkasa, CannformaticsPatents, Royalties, Other Intellectual Property: Royalties from my Oxford University Press text book Integrative Oncology William PirlHonoraria: WileyNo other potential conflicts of interest were reported.